Relaxation of purifying selection on live attenuated vaccine strains of the family Paramyxoviridae

Vaccine

Volumn 27, Issue 11, 2009, Pages 1685-1690

  Hughes, Austin L ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Live attenuated vaccine; Measles virus; Mumps virus; Newcastle disease virus; Paramyxovirus; Purifying selection

Indexed keywords

LIVE VACCINE;

ARTICLE; DRUG ANTIGENICITY; GENETIC VARIABILITY; IMMUNOGENICITY; MEASLES VIRUS; MUMPS VIRUS; NATURAL SELECTION; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UNINDEXED SEQUENCE; VACCINE PRODUCTION; VIRUS GENOME; VIRUS MUTATION; VIRUS REPLICATION;

ALGORITHMS; HUMANS; MEASLES VACCINE; MEASLES VIRUS; MUMPS VACCINE; MUMPS VIRUS; NEWCASTLE DISEASE VIRUS; PARAMYXOVIRIDAE; POLYMORPHISM, SINGLE NUCLEOTIDE; VACCINES, ATTENUATED; VIRAL VACCINES;

EID: 60849114399     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.01.036     Document Type: Article

References (39)

1. McCullers J.A. Evolution, benefits, and shortcomings of vaccine management. J Managed Care Pharm 13 7 Suppl. B (2007) S2-S6
2. Melnick J.L. Conventional viral vaccines and their influence on the epidemiology of disease. In: Dimmock N.J., Griffiths P.D., and Madeley C.R. (Eds). Control of virus diseases (1999), Cambridge University Press, Cambridge 3-19
3. Bonnet M.C., Dutta A., Weinberger C., and Plotkin S.A. Mumps vaccine strains and aseptic meningitis. Vaccine 24 49-50 (2006) 7037-7045
4. Bonnet M.C., and Dutta A. World wide experience with inactivated poliovirus vaccine. Vaccine 26 39 (2008) 4978-4983
5. Kamboj M., and Sepkowitz K.A. Risk of transmission associated with live attenuated vaccines given to healthy persons caring for or residing with an immunocompromised patient. Infect Control Hospital Immunol 28 6 (2007) 702-707
6. Cohen C., White J.M., Savage E.J., Glynn J.R., Choi Y., Andrews N., et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak. England Emerging Infect Dis 13 1 (2007) 12-17
7. Marin M., Nguyen H.Q., Langidrik J.R., Edwards R., Briand K., Papiana M.J., et al. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy. Clin Infect Dis 42 3 (2006) 315-319
8. Marin M., Quinlisk P., Shimabukuru T., Sahney C., Brown C., and LeBaron C.W. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students - Iowa 2006. Vaccine 26 29-30 (2008) 3601-3607
9. Velicko I., Müller L.L., Pebody R., Gergonne B., Aidyralieva C., Kostiuchenko N., et al. Nationwide measles epidemic in Ukraine: the effect of low vaccine effectiveness. Vaccine 26 52 (2008) 6980-6985
10. Hitchner S.B. Serendipity in science: discovery of the B-1 strain of Newcastle disease virus. Avian Dis 19 2 (1975) 215-223
11. Enders J.F., Katz S.L., Milovanovic M.L., and Holloway A. Studies of an attenuated measles virus vaccine. N Engl J Med 263 (1960) 153-159
12. Boroskin Y.S., Yamade A., Kaptsova T.I., Skvortsova O.I., Sinitsyna O.A., Takeuchi K., et al. Genetic evidence for variant selection in the course of dilute passaging of mumps vaccine virus. Res Virol 143 4 (1992) 279-283
13. Kimura M. The neutral theory of molecular evolution (1983), Cambridge University Press, Cambridge
14. Ohta T. Slightly deleterious mutant substitutions in evolution. Nature 246 5428 (1973) 96-98
15. Hughes A.L. Adaptive evolution of genes and genomes (1999), Oxford University Press, New York
16. Hughes A.L. Near neutrality: leading edge of the neutral theory of molecular evolution. Ann NY Acad Sci 1133 (2008) 162-179
17. Hughes A.L., Packer B., Welsch R., Bergen A.W., Chanock S.J., and Yeager M. Widespread purifying selection at polymorphic sites in human protein-coding loci. Proc Natl Acad Sci USA 100 26 (2003) 15754-15757
18. Hughes A.L. Evidence for abundant slightly deleterious polymorphisms in bacterial populations. Genetics 169 2 (2005) 553-558
19. Hughes A.L., and Hughes M.K. More effective purifying selection on RNA viruses than in DNA viruses. Gene 404 1-2 (2007) 117-125
20. Hughes A.L., and Piontkivska H. Nucleotide sequence polymorphism in circoviruses. Infect Genet Evol 8 2 (2008) 130-138
21. Thompson J.D., Gibson T.J., Plewniak F., Jeanmougin F., and Diggins D.G. The CLUSTAL X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25 24 (1997) 4876-4882
22. Saitou N., and Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4 4 (1987) 406-425
23. Tamura K., Dudley J., Nei M., and Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24 8 (2007) 1596-1599
24. Felsenstein J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution 39 4 (1985) 83-791
25. Han G.-Z., He C.-Q., Ding N.-Z., and Ma L.Y. Identification of a natural multi-recombinant of Newcastle disease virus. Virology 371 1 (2008) 54-60
26. Parks C.L., Lerch R.A., Walpita P.A., Wang H.-P., Sidhu M.S., and Udem S.A. Analysis of the noncoding regions of measles virus strains in the Edmonston lineage. J Virol 75 2 (2001) 921-933
27. Amexis G., Fineschi N., and Chumakov K. Correlation of genetic variability with safety of mumps vaccine Urabe AM9 strain. Virology 287 1 (2001) 234-241
28. Hanson R.P. Heterogeneity within strains of Newcastle disease virus: key to survival. In: Alexander D.J. (Ed). Newcastle disease (1988), Kluwer Academic Publishers, Boston 112-120
29. Goldhaft T.M. Historical note on the origin of the LaSota strain of Newcastle disease virus. Avian Dis 24 2 (1980) 297-301
30. Miller P.J., King D.J., Afonso C.L., and Suarez D.L. Antigenic differences among Newcastle disease virus strains of different genotypes used in vaccine formulation affect viral shedding after a virulent challenge. Vaccine 25 41 (2007) 7238-7246
31. Nei M., and Gojobori T. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 3 5 (1986) 418-426
32. Li W.-H. Unbiased estimates of the rates of synonymous and nonsynonymous substitution. J Mol Evol 36 1 (1993) 96-99
33. Yang Z., and Nielsen R. Estimating synonymous and nonsynonymous substitution rates under realistic evolutionary models. Mol Biol Evol 17 1 (2000) 32-43
34. Hughes A.L., and French J.O. Homologous recombination and the pattern of nucleotide substitution in Ehrlichia ruminantium. Gene 387 1-2 (2007) 31-37
35. Nei M., and Kumar S. Molecular evolution and phylogenetics (2000), Oxford University Press, New York
36. Swofford D.L. PAUP*: Phylogenetic analysis using parsimony (* and other methods) (2000), Sinauer, Sunderland, MA
37. Nei M. Molecular evolutionary genetics (1987), Columbia University Press, New York
38. Baričević M., Forčević D., Gulija T.K., Jug R., and Mažuran R. Determination of the coding and non-coding nucleotide sequences of genuine Edmonston-Zagreb master seed and current working seed lot. Vaccine 23 8 (2005) 1072-1078
39. Amexis G., Rubin S., Chizhikov V., Pelloquin F., Carbone K., and Chumakov K. Sequence diversity of Jeryl Lynn strain of mumps virus: quantitative mutant analysis for vaccine quality control. Virology 300 (2002) 171-179